Production (Stage)
Atara Biotherapeutics, Inc.
ATRA
$7.80
$0.3054.07%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -67.43% | -36.75% | 90.38% | -23.67% | -10.61% |
| Total Receivables | 498.85% | 11.01% | -44.88% | -93.28% | 5.65% |
| Inventory | -- | -23.78% | -25.44% | 16.57% | 65.71% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -56.48% | 9.73% | 57.24% | -26.37% | 27.60% |
| Total Current Assets | -58.11% | -29.35% | 47.18% | -41.36% | 4.48% |
|
|
|||||
| Total Current Assets | -58.11% | -29.35% | 47.18% | -41.36% | 4.48% |
| Net Property, Plant & Equipment | -22.11% | -13.46% | -7.36% | -6.74% | -6.50% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -8.35% | -7.57% | -6.98% | -6.70% | -20.15% |
| Total Assets | -43.14% | -23.55% | 21.68% | -29.04% | -0.14% |
|
|
|||||
| Total Accounts Payable | -68.31% | 103.49% | -59.15% | 84.06% | -22.53% |
| Total Accrued Expenses | -21.65% | -7.15% | 6.52% | -47.27% | -16.24% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -0.01% | -5.06% | 4.71% | -0.24% | 15.21% |
| Total Finance Division Other Current Liabilities | -83.19% | -18.27% | 8.14% | -12.64% | 58.23% |
| Total Other Current Liabilities | -83.19% | -18.27% | 8.14% | -12.64% | 58.23% |
| Total Current Liabilities | -64.41% | -13.72% | 5.20% | -17.94% | 27.04% |
|
|
|||||
| Total Current Liabilities | -64.41% | -13.72% | 5.20% | -17.94% | 27.04% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -11.07% | -10.58% | -8.94% | -8.28% | -7.65% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.23% | -4.12% | 2.04% | 1.20% | -47.03% |
| Total Liabilities | -43.26% | -11.52% | 2.23% | -13.44% | -0.44% |
|
|
|||||
| Common Stock & APIC | 0.22% | 0.31% | 2.21% | 0.34% | 1.74% |
| Retained Earnings | 1.85% | -0.62% | -1.08% | -0.95% | -1.61% |
| Treasury Stock & Other | -- | -63.64% | 257.14% | 74.55% | 73.04% |
| Total Common Equity | 43.39% | -7.45% | 18.34% | -12.78% | 0.93% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 43.39% | -7.45% | 18.34% | -12.78% | 0.93% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 43.39% | -7.45% | 18.34% | -12.78% | 0.93% |
|
|
|||||